|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.68 EUR | -1.75% |
|
-0.59% | -36.84% |
| Apr. 08 | Advicenne S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 25 | Advicenne: ODD designation in cystinuria | CF |
Advicenne S.A. reported sales results for the year 2022. For the period, the company reports sales of €3.7 million, up 13% compared to the previous year (2021: €3.3 million).
| 1st Jan change | Capi. | |
|---|---|---|
| -36.84% | 22.03M | |
| -4.66% | 86.13B | |
| +1.32% | 39.82B | |
| -19.27% | 30.42B | |
| +57.86% | 25.23B | |
| -16.09% | 15.36B | |
| -9.14% | 11.95B | |
| -17.69% | 11.6B | |
| -43.00% | 11.51B | |
| +5.24% | 8.71B |
ADVICENNE 
